This list is an analysis based on recent market events. It's not an investment recommendation.
About
Mirxes Holding Company Limited, a micro ribonucleic acid technology company, provides diagnostic solutions for the screening of cancer, cardiovascular, metabolic, and infectious diseases accessible across Singapore and China. The company offers GASTROClear, a blood-based miRNA detection panel consisting of 12 miRNA biomarkers for gastric cancer screening; LUNGClear, a lung cancer screening product candidate; and Fortitude COVID-19 RT-qPCR test kits. It also researches, develops, and manufactures biotechnology, life, and medical science related products. The company was founded in 2014 and is headquartered in Singapore.
The current price of 2629.HK is HK$12.41 HKD — it has decreased by -20.24% in the past 24 hours. Watch Mirxes Company stock price performance more closely on the chart.
What is Mirxes Company stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Hong Kong Exchange exchange Mirxes Company stocks are traded under the ticker 2629.HK.
Is Mirxes Company stock price growing?▼
2629.HK stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Mirxes Company has showed a -80.49% decrease.
What is Mirxes Company market cap?▼
Today Mirxes Company has the market capitalization of 3.43B
What is Mirxes Company revenue for the last year?▼
Mirxes Company revenue for the last year amounts to 82.2M HKD.
What is Mirxes Company net income for the last year?▼
2629.HK net income for the last year is -222.56M HKD.
How many employees does Mirxes Company have?▼
As of November 4, 2026, the company has 352 employees.
In which sector is Mirxes Company located?▼
Mirxes Company operates in the Health & Wellness sector.
When did Mirxes Company complete a stock split?▼
Mirxes Company has not had any recent stock splits.
Where is Mirxes Company headquartered?▼
Mirxes Company is headquartered in Singapore, Cayman Islands.